Biolase, Inc. (BIOL) financial statements (2021 and earlier)

Company profile

Business Address 4 CROMWELL
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
SIC 3843 - Dental Equipment and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18681291232
Cash and cash equivalents18681291232
Restricted cash and investments000000 
Receivables3911101099
Inventory, net of allowances, customer advances and progress billings11111212141313
Inventory11111212141313
Prepaid expense1      
Other current assets1      
Other undisclosed current assets1122212
Total current assets:35273336343555
Noncurrent Assets
Operating lease, right-of-use asset20
Property, plant and equipment1124441
Intangible assets, net (including goodwill)3333333
Goodwill3333333
Intangible assets, net (excluding goodwill)     00
Other noncurrent assets0000110
Total noncurrent assets:6557875
TOTAL ASSETS:41323943424259
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9101311151216
Accounts payable3565968
Accrued liabilities7586665
Employee-related liabilities      2
Taxes payable      0
Deferred revenue22
Debt 13     
Deferred revenue and credits3332
Customer advances and deposits0000
Contract with customer, liability2
Other undisclosed current liabilities      (2)
Total current liabilities:11261613181516
Noncurrent Liabilities
Long-term debt and lease obligation18011  0 
Long-term debt, excluding current maturities16 11    
Capital lease obligations   0 
Operating lease, liability20
Liabilities, other than long-term debt2210111
Deferred revenue and credits000 
Accounts payable and accrued liabilities0000111
Deferred revenue00
Deferred tax liabilities, net    1
Other liabilities110000 
Other undisclosed noncurrent liabilities 00011 
Total noncurrent liabilities:202110221
Total liabilities:31282714201717
Temporary equity, carrying amount 4     
Stockholders' equity
Stockholders' equity attributable to parent1001129222542
Preferred stock0      
Common stock0000000
Additional paid in capital262236228225201189185
Accumulated other comprehensive loss(0)(1)(1)(1)(1)(1)(1)
Accumulated deficit(251)(235)(217)(195)(178)(163)(143)
Total stockholders' equity:1001129222542
TOTAL LIABILITIES AND EQUITY:41323943424259

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues23384647524848
Revenue, net47524848
Cost of revenue(17)(24)(29)(32)(32)(33)(29)
Gross profit:6141715201618
Operating expenses(25)(30)(38)(33)(35)(36)(36)
Operating loss:(19)(16)(21)(18)(15)(20)(18)
Nonoperating income (expense)2(2)(1)1(0)(0)(1)
Investment income, nonoperating4     (0)
Foreign currency transaction gain (loss), before tax(0)(0)(0)1(0)(0)(0)
Interest and debt expense(0)(0)(0)   (0)
Other undisclosed income from continuing operations before equity method investments, income taxes      0
Loss from continuing operations before equity method investments, income taxes:(17)(18)(22)(17)(15)(20)(19)
Other undisclosed income from continuing operations before income taxes000    
Loss from continuing operations before income taxes:(17)(18)(21)(17)(15)(20)(19)
Income tax expense (benefit)(0)0(0)1(0)(0)(0)
Net loss attributable to parent:(17)(18)(22)(17)(15)(20)(19)
Preferred stock dividends and other adjustments(17)  (4)(2)  
Net loss available to common stockholders, diluted:(34)(18)(22)(21)(18)(20)(19)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(17)(18)(22)(17)(15)(20)(19)
Comprehensive loss:(17)(18)(22)(17)(15)(20)(19)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0)0(0)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(17)(18)(22)(17)(15)(21)(19)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: